Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing.
about
Skin models for the testing of transdermal drugsDefective control of pre-messenger RNA splicing in human diseaseClinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing.Vemurafenib-resistant BRAF selects alternative branch points different from its wild-type BRAF in intron 8 for RNA splicing.The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches.Small Molecule Modulators of Pre-mRNA Splicing in Cancer TherapySplice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy.Discoveries, target identifications, and biological applications of natural products that inhibit splicing factor 3B subunit 1.Novel splice-switching oligonucleotide promotes BRCA1 aberrant splicing and susceptibility to PARP inhibitor action.The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1.Targeting MDM4 Splicing in Cancers.Therapeutic targeting of splicing in cancer.RNA editing-dependent epitranscriptome diversity in cancer stem cells.Modulators of alternative splicing as novel therapeutics in cancer.The role of alternative splicing in cancer.RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AMLExploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer.Flow cytometric analysis identifies changes in S and M phases as novel cell cycle alterations induced by the splicing inhibitor isoginkgetin.Identification of Single Nucleotide Non-coding Driver Mutations in Cancer.Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.
P2860
Q28074471-B98E155C-4BFC-4468-81E5-AE64136B0DC8Q28077564-915D491C-95CC-4BCB-B496-F2669553D9DBQ33660469-04870D2E-4B15-47DD-85A4-9A34AB0AE48DQ36393134-45007452-2789-40F2-8783-D6AC04324742Q36410173-221D4E00-779B-46E6-97EE-13D912371E8BQ36447664-CE234E3C-287F-46BA-9A2A-FA640D5694F3Q37690917-27B7556C-A35C-47D1-BDD5-44484BF29C72Q38712211-0B5553D0-B701-453C-97BB-2D87329785FBQ38725261-A9B74500-D6BE-4E73-AD77-797BE9370A0EQ38758644-363F7E3F-CCD7-4266-85BA-7410E77E88C2Q38946224-848AD032-C5DB-443C-BF63-61C7796F39BAQ38948363-2095D2B0-F9D3-4E24-987E-02BE77D2A11CQ39247132-48415D91-A2A3-4476-8138-9A45C52CA0C2Q41904460-C6FC52FA-1971-4FF2-9BFC-B59351B139C0Q42282317-62BFBC9C-C9F8-4A49-BD98-E2655ACB7210Q42734570-0C994A31-2A04-40B8-86A3-D9344E439A76Q47784889-CE16ECCB-0161-437F-9D3C-0D7562B6ECA5Q48235204-7A1B5042-3FA2-4B98-968B-334C701E4DE0Q49884827-CE89AAAC-382F-4E02-AA2D-C1634BECC2E3Q54981975-63CB3E46-EFBE-47CE-AF5A-A04036C35170
P2860
Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing.
@ast
Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing.
@en
type
label
Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing.
@ast
Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing.
@en
prefLabel
Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing.
@ast
Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing.
@en
P2093
P2860
P356
P1476
Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing.
@en
P2093
Bruce A Shapiro
Maayan Salton
Poulikos I Poulikakos
Tom Misteli
Wojciech K Kasprzak
P2860
P2888
P356
10.1038/NCOMMS8103
P407
P577
2015-05-14T00:00:00Z